I asked Aristides Capital Group last week how its $4 OPK short position was coming along
September 22 at 11:23pm
How is your OPK short position coming along since last October when it was in the $4 range?
September 23 at 3:10pm
it's larger now.
September 25 at 10:28pm
That's excellent. Thanks for shorting more. Looking forward to the 34 million squeeze.
September 26 at 8:21am
squeeze is the only way a long position might pay off in this company, so good luck.
September 28 at 10:38am
Well thanks for your reply. You have your position and I respect that, but so far it hasn't worked out very well for you.
How exactly when I bought in the $5 range is a squeeze the only way that is going to pay off?
September 29 at 8:08am
Company is truly a Potemkin village. Just a bunch of minor drug and diagnostic assets. I can't get a valuation above $2.50 even in a very optimistic scenario. If you look at the sell side, everyone covering has done business with them. If you look at the buy side, there is very little institutional ownership. The only really true counterargument is that things have been this way for a while and the stock still goes up; that works until it suddenly doesn't.